Drew Armstrong, the new executive editor of biopharmaceutical industry news site Endpoints News, said it would expand with six new positions.
Armstrong writes, “We’re a newsroom of experts focused on the biopharma industry – with the ability and ambition to compete with (and beat!) the biggest publications for scoops and smart analysis on our turf.
“To that end, we’re hiring: Today we’ve posted six new jobs at Endpoints that will expand the size and ambition of our newsroom. You can find the listings here (along with descriptions of our great benefits and our work-from-home/anywhere policy). We’re adding to our editing ranks, and plan to hire writers and reporters to boost our science, venture capital and regulatory coverage.
“We want people who are passionate about covering medical innovation and business, but also who see the journalism world the way we do: who believe that focus creates greatness, and that the next thriving newsrooms will be built by being smarter and breaking more news than anyone else on your beat.”
Read more here.
Dow Jones & Co., the parent of The Wall Street Journal, Barron's, MarketWatch.com and Investor's…
The Wall Street Journal is seeking a White House reporter in Washington, DC, to break…
Ben Pershing, the politics editor of The Wall Street Journal, is leaving the news organization.…
New York Times executive editor Joe Kahn sent out the following on Friday: A January 2010 front…
Brent Jones, the senior vice president of training, culture and community at Dow Jones, is…
The Wall Street Journal is looking for an editor to lead its coverage of logistics…